Monthly Archives: April 2017

Australasian Viral Hepatitis Elimination Conference 2017

The inaugural Australasian Viral Hepatitis Elimination Conference 2017, taking place at the Pullman Cairns International, Queensland, 10–11 August 2017, aims to gather those working in the field of Viral Hepatitis – as well as policy makers, researchers, primary health care providers and other individuals committed towards virtual hepatitis elimination. The program will present the latest […]

Hepatitis B Vaccine Shortage

Hepatitis ACT understands from pharmaceutical company GlaxoSmithKline (GSK) that there is a national shortage of the adult dose of the hepatitis B vaccine, and as a result they say “GSK prioritises hepatitis B vaccine availability for those most at risk of infection and confirms uninterrupted supply of Engerix-B to all Australian State, Territory and Federal […]